Form 4: AngioDynamics SVP/GM, Vascular Access, Chad Thomas Campbell, Reports Stock Transactions
SEC Form 4 Filing
Chad Thomas Campbell, SVP/GM, Vascular Access at AngioDynamics, reports acquisition and disposition of common stock related to performance share units.
Summary
- On July 17, 2024, Chad Thomas Campbell, SVP/GM, Vascular Access at AngioDynamics, acquired 6,600 shares of common stock through the vesting and settlement of performance share units granted on July 21, 2021.
- Simultaneously, Campbell disposed of 2,379 shares to satisfy tax withholding obligations related to the vesting of these performance share units at a price of $7.4.
- Following these transactions, Campbell directly owns 67,808 shares of AngioDynamics common stock.
- The performance share units were granted on July 21, 2021, with the number of shares earned based on pre-determined performance metrics for fiscal years 2022, 2023, and 2024.
- Based on the performance metrics, 6,600 shares were issued, and the remaining shares were forfeited.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects routine transactions related to executive compensation. The vesting of performance shares suggests that some performance targets were met, which is mildly positive, but the sale of shares for tax purposes is a neutral event.
Positives
- The vesting of performance share units indicates that certain performance goals were met, which could be viewed positively.
Negatives
- The sale of shares to cover tax obligations could be seen as a slight negative, although it's a common practice.
Risks
- The value of the performance share units is tied to the company's performance, so any future underperformance could impact the value of these units.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives. This filing indicates the vesting of performance-based compensation, which is a common practice in publicly traded companies to align executive incentives with shareholder value.
Stakeholder Impact
- The vesting of performance shares aligns executive compensation with company performance, potentially benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/21/2021 | Date of the grant of performance share units to the reporting person. |
| 07/17/2024 | Date of the stock acquisition and disposition. |
| 08/02/2024 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.